Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Dermatological Medicine
Volume 2017, Article ID 2386234, 3 pages
Case Report

Repigmentation of Tenacious Vitiligo on Apremilast

1University of Toledo College of Medicine and Life Sciences, 3000 Arlington Avenue, Toledo, OH 43614, USA
2Department of Dermatology, University of Toledo Medical Center, 3000 Arlington Avenue, Toledo, OH 43614, USA

Correspondence should be addressed to Sara B. Huff; ude.odelotu@eornom.aras

Received 26 July 2017; Accepted 8 October 2017; Published 6 November 2017

Academic Editor: Kowichi Jimbow

Copyright © 2017 Sara B. Huff and Lorie D. Gottwald. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Supplementary Material

Timeline showing the patient’s continual use of apremilast 30 mg BID and when steroid bolstering occured.

  1. Supplementary Material